Both This medication and the drug represent innovative strategies to addressing type 2 diabetes, and increasingly, obesity. Semaglutide is a twin agonist that works on two hormones involved in metabolism: GLP-1 and another incretin. Mounjaro, often viewed as a trade name for this compound, acts s